Add to Favorites Newsroom RSS Share
Houston, TX USA

Our News on Newswise

152884_Heymach_J1.jpg

Poziotinib Maintains High Response Rate Against Harmful Lung Cancer Mutation

A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide unprecedented response rates among stage 4 non-small cell lung cancer patients with genetic mutations that have previously defied treatment.
24-Sep-2018 4:05 PM EDT Add to Favorites

MD Anderson hosts Biden Cancer Community Summit

The University of Texas MD Anderson Cancer Center today joined with more than 450 communities and institutions across the country in hosting a Biden Cancer Community Summit, organized under the charge of the Biden Cancer Initiative. The Summit aims...
21-Sep-2018 3:05 PM EDT Add to Favorites

148380_Sharma_P12.jpg

MD Anderson immunotherapy expert Sharma wins Coley Award

Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology at The University of Texas MD Anderson Cancer Center, has been recognized for her innovative work understanding factors that enhance and hinder cancer...
11-Sep-2018 8:00 AM EDT Add to Favorites

Gan.jpg

Study Links BAP1 Protein to Tumor Suppression in Kidney, Eye, Bile Duct and Mesothelioma Cancers

Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other cancers by regulating a form of cell death called...
7-Sep-2018 8:00 AM EDT Add to Favorites

219300_Tawbi_H.jpg

Combination Immunotherapy Shrinks Melanoma Brain Metastases

Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial reported in the New England Journal of Medicine led by an investigator at The University of Texas MD Anderson Cancer Center.
20-Aug-2018 2:05 PM EDT Add to Favorites

150401_LItton_J.jpg

PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA mutations

In a randomized, Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, the PARP inhibitor talazoparib extended progression-free survival (PFS) and improved quality-of-life measures over available chemotherapies for...
15-Aug-2018 10:05 AM EDT Add to Favorites

MD Anderson and Accelerator Life Science Partners Launch Magnolia Neurosciences to Speed Development of Neuroprotective Therapies

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, today announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of...
13-Aug-2018 6:00 AM EDT Add to Favorites

MD Anderson and Jazz Pharmaceuticals collaborate to evaluate potential treatment options for hematologic malignancies

The University of Texas MD Anderson Cancer Center and Jazz Pharmaceuticals plc today announced a five-year collaboration agreement with a goal of evaluating therapies for multiple hematologic malignancies, including acute myeloid leukemia (AML) and...
6-Aug-2018 9:00 AM EDT Add to Favorites


see all news

Our Experts on Newswise

BenjaminSmith.jpg

Mastectomy Plus Reconstruction Has Highest Rate of Complication, Complication-Related Costs of Guideline-Concordant Therapies for Early Breast Cancer

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Liang_H_Bronto.jpg

Can Gender Play a Role in Determining Cancer Treatment Choices?

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

ZhiminLu.jpg

MD Anderson Study Reveals New Insight Into Tumor Progression

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Lee_M.jpg

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

204929_Chhatwal_Jjpg.jpg

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

see all experts

Our YouTube Videos

About

About section not configured. Is this your member page? Login to edit, or contact member@newswise.com to configure this module.

Contacts

Clayton Boldt
Senior Communications Specialist

713-792-9518

Katrina Burton
Senior Communications Specialist

713-792-8034

Leslie Friedman
Communications professional

713-563-9340

Scott Merville
Program Manager

713-792-0661

Julie Penne
Assistant Director

713-792-0662

Allison Schaffer
Senior Communications Specialist

713-745-1357

Twitter

Chat now!